NO20021079L - Ikke-aromatiske östrogene steroider med en hydrogensubstituent i posisjon 11 - Google Patents

Ikke-aromatiske östrogene steroider med en hydrogensubstituent i posisjon 11

Info

Publication number
NO20021079L
NO20021079L NO20021079A NO20021079A NO20021079L NO 20021079 L NO20021079 L NO 20021079L NO 20021079 A NO20021079 A NO 20021079A NO 20021079 A NO20021079 A NO 20021079A NO 20021079 L NO20021079 L NO 20021079L
Authority
NO
Norway
Prior art keywords
alkyl
alkynyl
alkenyl
alpha
hydrogen substituent
Prior art date
Application number
NO20021079A
Other languages
English (en)
Norwegian (no)
Other versions
NO20021079D0 (no
Inventor
Hubert Jan Jozef Loozen
Gerrit Herman Veeneman
Wilhelmus Gerardus Ed Schoonen
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20021079D0 publication Critical patent/NO20021079D0/no
Publication of NO20021079L publication Critical patent/NO20021079L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20021079A 1999-09-06 2002-03-05 Ikke-aromatiske östrogene steroider med en hydrogensubstituent i posisjon 11 NO20021079L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99202900 1999-09-06
PCT/EP2000/008406 WO2001018027A1 (en) 1999-09-06 2000-08-28 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11

Publications (2)

Publication Number Publication Date
NO20021079D0 NO20021079D0 (no) 2002-03-05
NO20021079L true NO20021079L (no) 2002-04-29

Family

ID=8240610

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021079A NO20021079L (no) 1999-09-06 2002-03-05 Ikke-aromatiske östrogene steroider med en hydrogensubstituent i posisjon 11

Country Status (24)

Country Link
US (1) US6677329B1 (zh)
EP (1) EP1224204B1 (zh)
JP (1) JP2003508541A (zh)
KR (1) KR20020092907A (zh)
CN (2) CN100354299C (zh)
AT (1) ATE295851T1 (zh)
AU (1) AU770331B2 (zh)
BR (1) BR0013769A (zh)
CA (1) CA2382489C (zh)
CZ (1) CZ2002831A3 (zh)
DE (1) DE60020260T2 (zh)
EC (1) ECSP013947A (zh)
ES (1) ES2241657T3 (zh)
HU (1) HUP0202595A3 (zh)
IL (2) IL148116A0 (zh)
MX (1) MXPA02001831A (zh)
NO (1) NO20021079L (zh)
NZ (1) NZ517281A (zh)
PL (1) PL353826A1 (zh)
RU (1) RU2245886C2 (zh)
SK (1) SK3282002A3 (zh)
TR (1) TR200200575T2 (zh)
WO (1) WO2001018027A1 (zh)
ZA (1) ZA200201250B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000059920A2 (en) * 1999-04-06 2000-10-12 Akzo Nobel N.V. Orally active 7.alpha.-alkyl androgens
CN100354299C (zh) * 1999-09-06 2007-12-12 欧加农股份有限公司 在11位带有烃取代基的非芳香族雌激素甾族化合物
WO2001098322A1 (en) * 2000-06-22 2001-12-27 Northeastern University Novel steroidal antiestrogens and antiandrogens and uses thereof
US8173628B2 (en) * 2000-06-22 2012-05-08 Northeastern University Steroidal antiestrogens and antiandrogens and uses thereof
SK882003A3 (en) * 2000-07-28 2003-07-01 Akzo Nobel Nv 16alpha-substituted steroid compounds, pharmaceutical composition comprising same and their use
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
EP3423464B1 (en) * 2016-03-03 2021-05-26 Crystal Pharma, S.A.U. Process and new intermediates for the preparation of 11-methylene steroids
CN114249789B (zh) * 2020-09-23 2023-06-02 湖南普尔生物医药有限公司 一种7α-甲基-3,3-二甲氧基-5(10)-雄烯-17-酮的制备方法
CN114409717B (zh) * 2021-12-17 2023-03-17 湖南科益新生物医药有限公司 替勃龙中间体醚化物和替勃龙的制备方法
CN114230627B (zh) * 2021-12-31 2023-09-15 湖南新合新生物医药有限公司 一种倍他米松环氧水解物中间体的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3092645A (en) * 1961-12-28 1963-06-04 Searle & Co Esters of 17alpha-alkynylester-5(10)-ene-3beta, 17beta-diols
GB1110792A (en) * 1964-04-07 1968-04-24 Res Inst Medicine Chem Novel 5(10)-dehydro-steroids
US3465010A (en) 1966-11-22 1969-09-02 Searle & Co 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof
US3377366A (en) * 1966-12-02 1968-04-09 Searle & Co 17alpha-alkynyl/alkenyl-11, 13beta-dialkylgon-5(10)-en-3-ones and esters thereof
US3652606A (en) * 1970-08-07 1972-03-28 Searle & Co 3-oxygenated 11beta-methylestr-4-en-17beta-ol and esters thereof
AU572589B2 (en) * 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints
ZA941464B (en) * 1993-03-05 1994-09-27 Akzo Nv Use of pregnane derivative
AU756882B2 (en) * 1998-03-09 2003-01-23 Akzo Nobel N.V. New contraceptive kit
CN100354299C (zh) * 1999-09-06 2007-12-12 欧加农股份有限公司 在11位带有烃取代基的非芳香族雌激素甾族化合物

Also Published As

Publication number Publication date
HUP0202595A2 (hu) 2002-12-28
PL353826A1 (en) 2003-12-01
ECSP013947A (es) 2002-09-27
DE60020260T2 (de) 2006-01-19
CA2382489A1 (en) 2001-03-15
AU7511700A (en) 2001-04-10
CZ2002831A3 (cs) 2002-05-15
MXPA02001831A (es) 2002-10-23
SK3282002A3 (en) 2002-06-04
IL148116A0 (en) 2002-09-12
DE60020260D1 (de) 2005-06-23
BR0013769A (pt) 2002-04-30
EP1224204A1 (en) 2002-07-24
IL148116A (en) 2006-10-31
KR20020092907A (ko) 2002-12-12
ZA200201250B (en) 2003-07-30
US6677329B1 (en) 2004-01-13
ES2241657T3 (es) 2005-11-01
NO20021079D0 (no) 2002-03-05
TR200200575T2 (tr) 2002-06-21
CN100354299C (zh) 2007-12-12
JP2003508541A (ja) 2003-03-04
NZ517281A (en) 2003-09-26
RU2245886C2 (ru) 2005-02-10
CA2382489C (en) 2008-03-11
CN1372565A (zh) 2002-10-02
CN1637016A (zh) 2005-07-13
EP1224204B1 (en) 2005-05-18
AU770331B2 (en) 2004-02-19
HUP0202595A3 (en) 2004-06-28
CN1185249C (zh) 2005-01-19
ATE295851T1 (de) 2005-06-15
WO2001018027A1 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
NO20021079L (no) Ikke-aromatiske östrogene steroider med en hydrogensubstituent i posisjon 11
DE69327096T2 (de) 17-substituierte steroide, verwendbar bei behandlung von krebs
RS20070075A (en) 15beta-substituted steroids having selective estrogenic activity
DK1272504T3 (da) 8.Beta-hydrocarbylsubstituerede östradiener til anvendelse som selektive östrogener
MX9304541A (es) Esteriodes de 17-espirometileno.
BR9508868A (pt) Preparações farmacêuticas contendo derivados de estra 1,3,5,(10)-trieno e preparação farmacêutica
NO20013632D0 (no) Steroide sulfataseinhibitorer og fremgangsmåter for å fremstille og anvende disse
RU2002108723A (ru) Неароматические эстрогенные стероиды с углеводородным заместителем в положении 11
HUP0301592A2 (hu) 16alfa-metil- vagy etil-szubsztituált ösztrogének és ezeket tartalmazó gyógyszerkészítmények
NO931951D0 (no) 2beta,19-metylenaminobroede steroider som aromataseinhibitorer
ATE40140T1 (de) Aromatase inhibierende steroide.
DK1196428T3 (da) 11-beta-aryl-17,17-spirothiolan-substituerede steroider
TW333536B (en) 14-17-C2-bridged steroids
AR010857A1 (es) Esteroides sustituidos en la posicion 11, su procedimiento de preparacion, su aplicacion como medicamento y las composiciones farmaceuticas que loscontienen
CO5261633A1 (es) Compuestos estrogenicos
CO5251432A1 (es) Derivados de 3-metileno esteroides
MXPA03005224A (es) Esteroides de metileno como androgenos novedosos.
NZ506049A (en) Steroid derivatives; useful for selectively supplementing oestrogen deficiency in the central nervous system
YU151591A (sh) Postupak za etinilovanje 17-ketosteroida

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application